menu search

ABMD / 3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio

3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio
Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line. Read More
Posted: Dec 22 2022, 09:02
Author Name: Zacks Investment Research
Views: 110523

ABMD News  

3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio

By Zacks Investment Research
December 22, 2022

3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio

Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line. more_horizontal

3 Reasons to Hold Abiomed (ABMD) Stock in Your Portfolio

By Zacks Investment Research
September 2, 2022

3 Reasons to Hold Abiomed (ABMD) Stock in Your Portfolio

Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line. more_horizontal

Here's Why You Should Hold on to Abiomed (ABMD) Stock For Now

By Zacks Investment Research
June 17, 2022

Here's Why You Should Hold on to Abiomed (ABMD) Stock For Now

Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line. more_horizontal

Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now

By Zacks Investment Research
May 16, 2022

Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now

Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line. more_horizontal

Abiomed CEO discusses company growth and combining products with supportive technology

By CNBC Television
March 28, 2022

Abiomed CEO discusses company growth and combining products with supportive technology

The "Mad Money" host spoke with Abiomed CEO Mike Minogue on Monday's episode of the show. more_horizontal

Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now

By Zacks Investment Research
March 15, 2022

Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now

Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line. more_horizontal

Abiomed Inc. (ABMD) CEO Mike Minogue on Q3 2022 Results - Earnings Call Transcript

By Seeking Alpha
February 3, 2022

Abiomed Inc. (ABMD) CEO Mike Minogue on Q3 2022 Results - Earnings Call Transcript

Abiomed Inc. (ABMD) CEO Mike Minogue on Q3 2022 Results - Earnings Call Transcript more_horizontal

Abiomed Inc. (ABMD) CEO Mike Minogue on Q3 2022 Results - Earnings Call Transcript

By Seeking Alpha
February 3, 2022

Abiomed Inc. (ABMD) CEO Mike Minogue on Q3 2022 Results - Earnings Call Transcript

Abiomed Inc. (ABMD) CEO Mike Minogue on Q3 2022 Results - Earnings Call Transcript more_horizontal


Search within

Pages Search Results: